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A B S T R A C T
The lack of eﬃcient and cost-eﬀective methods for gene delivery has signiﬁcantly hindered the applications of
gene therapy. In this paper, a simple one step and cost eﬀective salting-out method has been explored to fab-
ricate silk-PEI nanoparticles (SPPs) and magnetic-silk/PEI core-shell nanoparticles (MSPPs) for targeted delivery
of c-myc antisense oligodeoxynucleotides (ODNs) into MDA-MB-231 breast cancer cells. The size and zeta po-
tential of the particles were controlled by adjusting the amount of silk ﬁbroin in particle synthesis. Lower surface
charges and reduced cytotoxicity were achieved for MSPPs compared with PEI coated magnetic nanoparticles
(MPPs). Both SPPs and MSPPs were capable of delivering the ODNs into MDA-MB-231 cells and signiﬁcantly
inhibited the cell growth. Through magnetofection, high ODN uptake eﬃciencies (over 70%) were achieved
within 20min using MSPPs as carriers, exhibiting a signiﬁcantly enhanced uptake eﬀect compared to the same
carriers via non-magnetofection. Both SPPs and MSPPs exhibited a signiﬁcantly higher inhibition eﬀect against
MDA-MB-231 breast cancer cells compared to human dermal ﬁbroblast (HDF) cells. Targeted ODN delivery was
achieved using MSPPs with the help of a magnet, making them promising candidates for targeted gene therapy
applications.
1. Introduction
Gene therapy has shown great potential for the treatment of many
diseases (Zhao et al., 2007; Zhang et al., 2014; Zhang et al., 2016).
Eﬃcient gene therapy requires the delivery of genes to the cell nucleus
or cytoplasm replacing or regulating the defective genes (Zhang et al.,
2014). However, several intracellular barriers such as the cell mem-
brane and endosome membrane have signiﬁcantly reduced its eﬃ-
ciency (De Smedt et al., 2005; Pack et al., 2005). Therefore, carriers are
needed to help the gene delivery (Zhang et al., 2014). Eﬃcient and cost-
eﬀective carriers are particularly desired for clinical applications.
Due to the potential toxicity and immunogenicity concerns of viral
systems (El-Aneed, 2004; Plank et al., 2003; Lungwitz et al., 2005),
non-viral gene delivery systems have been explored as an alternative
method for gene therapy (Lungwitz et al., 2005; Zhang et al., 2014;
Zhang et al., 2016). The advantages of non-viral systems include low
cost, ease of fabrication and modiﬁcation, and high in vivo stability
(Zhang et al., 2016). One of the most eﬃcient and cost-eﬀective agents
is polyethyleneimine (PEI) (Lungwitz et al., 2005; Dey et al., 2011;
Xiang et al., 2007; Forrest et al., 2003; Seow et al., 2013). Once mixed
with DNAs, PEI is able to condense DNAs into nano complexes that are
suitable for the cell internalization through endocytosis (Zhang et al.,
2014; Wang et al., 2009). In addition, PEI is able to destabilize the
endosomal membrane by the proton sponge eﬀect to protect DNAs
against degradation and facilitate the release of DNAs from endosomes
into cytoplasm (Zhang et al., 2014; Wang et al., 2009; Dey et al., 2011;
Xiang et al., 2007). Despite its high transfection eﬃciency, the appli-
cations of PEI are still limited by its inherent problems such as high
cytotoxicity and lack of targeting (Forrest et al., 2003). Attempts have
been made to improve targeting by developing PEI coated magnetic
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nanoparticles (MPPs) for gene delivery through magnetofection (Zhang
et al., 2014; Zhang et al., 2016), in which an external magnetic ﬁeld
was used to enhance the transfection eﬃciencies by rapidly con-
centrating the magnetic vectors on the cell surface (Huth et al., 2004).
However, MPPs still possess signiﬁcant cytotoxic eﬀects and lead to
a decreased viability to many cell lines (Hoskins et al., 2012; Hoskins
et al., 2012; Strojan et al., 2017; Du et al., 2016). Hoskins et al. (2012)
investigated this by exposing MCF-7, SH-SY5Y and U937 cells to
100 µg/ml of MPPs and observed cell viability decreased to 50%, 70%
and 80% respectively after a 24 h incubation. When the incubation time
was increased to 7 days, the cell viability of these cells decreased to
20%, 10%, and 30% respectively (Hoskins et al., 2012). To further re-
duce the cytotoxicity of MPPs, various approaches have been in-
vestigated (Hoskins et al., 2012; Hoskins et al., 2012; Strojan et al.,
2017; Du et al., 2016). Hoskins et al. (2012) reported that MCF-7, SH-
SY5Y and U937 cells exhibited viabilities over 95% after 24 h in-
cubating with MPPs-PEG and around 90% after 7 days. Strojan et al.
(2017) fabricated glutathione modiﬁed PEI coated magnetic nano-
particles (GSH NPs) by adding glutathione during nanoparticle synth-
esis and reported that glutathione reduced 30% cytotoxic eﬀects to
CHO cells. Another example is reported by Du et al. (2016), where PEI
was modiﬁed with lactose at diﬀerent lactosylation degrees (6.8% and
11.7%) and then coated onto magnetic nanoparticles (MNPs). The re-
sulting lactose modiﬁed MPPs showed reduced cytotoxicity to RAW
264.7 cells compared with unmodiﬁed MPPs. However, the above
particles have limited manipulation of the size and zeta potential. Only
the GSH NPs have been used for gene delivery test and the eﬃciency
was compromised (Strojan et al., 2017).
In this work, a simple one-step salting-out method has been ex-
plored to fabricate silk-PEI nanoparticles (SPPs) and magnetic-silk/PEI
core-shell nanoparticles (MSPPs) for targeted delivery of c-myc anti-
sense oligodeoxynucleotides (ODNs) into MDA-MB-231 breast cancer
cells. Silk ﬁbroin (SF) protein from cocoons of Bombyx mori is an FDA
approved, natural material which has been widely used to form various
biomaterials including gels, sponges and ﬁlms for diﬀerent medical
applications such as drug delivery, tissue engineering and wound
dressing (Vepari and Kaplan, 2007). Excellent biocompatibility (Dal Pra
et al., 2005), tuneable biodegradability (Horan et al., 2005) and easy
processing (Vepari and Kaplan, 2007) of SF has made it a promising
biomaterial for drug and gene delivery systems (Vepari and Kaplan,
2007; Liu et al., 2014; Yu et al., 2016; Li et al., 2014; Mathur and Gupta,
2010). However, the fabrication of magnetic-silk/PEI core-shell nano-
particles (MSPPs) and their performance as gene delivery carriers has
not yet been reported. Here, SF was used to help the particle formation
through salting-out and manipulate the size and zeta potential of the
nanoparticles, as well as reduce the cytotoxicity of MPPs. The mor-
phology, size and zeta potential of the nanoparticles and their ODN
complexes were determined by DLS, AFM and TEM. Toxicity of nano-
particles with diﬀerent SF percentages and the cell growth inhibition
eﬀects using their ODN complexes against MDA-MB-231 cells and HDF
cells were determined through the MTT assay. The cell uptake proﬁles
and the localization of nanoparticle-ODN complexes were investigated
by ﬂow cytometry and confocal microscopy. The results show that the
MSPPs were eﬃcient carriers for ODN delivery, therefore they are
promising candidates for targeted delivery of ODNs into cancer cells.
2. Materials and methods
2.1. Materials
Na2HPO4 (S7907), NaH2PO4 (S8282), ammonium hydroxide
(221228), DMSO (Dimethyl sulfoxide, D5879), branched poly-
ethyleneimine (408727) were purchased from SIGMA-ALDRICH.
Bombyx mori silk was obtained from Jiangsu, P.R. China. Single-
stranded human c-myc antisense oligodeoxynucleotides (5-AAC-GTT-
GAG-GGG-CAT-3, with and without 5-FAM (carboxyﬂuorescein-5-
succimidyl ester) labelled) were purchased from Eurogentec Ltd. (UK)
and were HPLC puriﬁed. Iron (II) chloride tetrahydrate (44939), Iron
(III) chloride hexahydrate (44944), Oligofectamine (12252011), Alexa
Fluor® 568 phalloidin (A12380), MTT (M6494), foetal bovine serum
(FBS, 10500064) and DAPI (4, 6-Diamidino-2-phenylindole dihy-
drochloride, D1306) were purchased from Thermo Fisher Scientiﬁc.
MDA-MB-231 cells (Human Caucasian Breast Adenocarcinoma cells)
were purchased from ECACC. HDF cells were provided by the Sheﬃeld
RNAi screening facility. RPMI (Roswell Park Memorial Institute) 1640
Medium (BE 12-167F), PBS (Dulbecco's Phosphate Buﬀered Saline,
BE17-512F), L-glutamine (17-605F) were purchased from Lonza®.
2.2. Preparation of silk ﬁbroin solution
Silk ﬁbroin (SF) solutions were prepared based on the protocol
previously reported (Song et al., 2017). Brieﬂy, silk ﬁbres were boiled
for 30min in 0.02M Na2CO3 solution and then rinsed 3 times with DI
water to remove sericin (this step is also called degumming). The de-
gummed SF was dried overnight in a drying oven at 60 °C before added
into a ternary system (CaCl2/Ethanol/water at molar ratio of 1:2:8) and
heated to keep the system temperature at 75 °C for 3 h with stirring. The
solid SF was dissolved in the solution within 30min. The SF solution
was dialysed in a cellulose dialysis tube (12.5 KDa molecular weight cut
oﬀ) against DI water for 3 days, during which the DI water was replaced
at least 5 times per day. The resulting solution was centrifuged twice at
10,000g for 10min to remove the impurities before stored at 4 °C.
2.3. Preparation of magnetic nanoparticles (MNPs)
Iron (III) chloride hexahydrate (4 g) and iron (II) chloride tetra-
hydrate (4.5 g) were each dissolved in 150ml DI water and degassed
with nitrogen for 30min to remove the oxygen in the solutions. The
solutions were then mixed in a 500ml round-bottom ﬂask and 15ml of
ammonium hydroxide was added under vigorous stirring in a nitrogen
atmosphere at room temperature for 2 h. The magnetic nanoparticles
(MNPs) were collected with strong Neodymium magnets and washed at
least 5 times with DI water to remove any impurity. The particles were
then washed with ethanol and dried over night at room temperature
and stored for future usage.
2.4. Preparation of SPPs and MSPPs
2.4.1. Preparation of SPPs
SF solution (5mg/ml) and PEI solution (5mg/ml) were mixed at
diﬀerent volume ratios (10:90, 25:75, 50:50, 75:25 and 90:10) to pre-
pare SF/PEI mixtures. 2 ml of SF/PEI mixtures were then added to
10ml of sodium phosphate solutions (Na2HPO4+NaH2PO4) with an
ionic strength of 1.25M at pH 8. The prepared solutions were kept at
room temperature (20 °C) for 6 h to allow the formation of particles.
The resultant solution was then centrifuged at 20,000g for 15min to
collect the SPPs. The particles were washed several times with DI water
to remove excess salts before further characterizations. SF and PEI
particles were prepared using the same method as controls.
2.4.2. Preparation of MSPPs
MNPs (5mg) were dispersed in 50ml of sodium phosphate solution
to prepare a MNP-salt mixture. 2 ml of SF/PEI mixtures (5 mg/ml) at
diﬀerent SF/PEI concentration ratios (as above) were then blended with
10ml of MNP-salt mixtures and the resulting solutions were kept at
room temperature (20 °C) for 6 h to allow the formation of MSPPs. The
particles were then washed and collected with Neodymium magnets.
Magnetic SF and magnetic PEI particles were prepared by the same
method as controls.
W. Song et al. ,QWHUQDWLRQDO-RXUQDORI3KDUPDFHXWLFV²

2.5. Preparation of MSPP-ODN complexes
MSPP-ODN complexes were prepared by mixing the MSPP solutions
with ODN solutions. An ODN aqueous solution of 0.2mg/ml was pre-
pared. MSPPs were dispersed in DI water to obtain MSPP solutions at
diﬀerent concentrations (0.2, 1.2, 2.4, 5, 10, 20mg/ml). 100 µl of
prepared ODN solution was then added to 100 µl MSPP solutions and
mixed under gentle shaking until a homogenous dispersion was
achieved. Finally, the mixed solution was incubated for 30min at room
temperature. The ﬁnal ODN concentration in the mixed solution was
ﬁxed at 0.1mg/ml and the MSPP concentrations were varied from 0.1
to 10mg/ml to achieve diﬀerent MSPP/ODN mass ratios (1:1, 6:1, 12:1,
25:1, 50:1, 100:1). MSPP/ODN mixed solutions with higher con-
centrations of ODN (1 or 2mg/ml) and MSPPs (12 or 24mg/ml) were
also prepared with similar process. The prepared dispersions were di-
luted in PBS before added into cell cultures.
2.6. Particle characterization
2.6.1. Dynamic light scattering and zeta potential analysis
Particle aggregation size and zeta potential were carried out by a
dynamic light scattering (DLS) analyser (NanoBrook 90 plus Pals
Particle size Analyzer, Brookhaven Instrument, NY, USA). Particles
were dispersed in DI water in a cuvette before placed in the sample cell.
A diode laser with wavelength of 660 nm was used. All experiments
were conducted at a measurement temperature of 18 °C controlled by a
circulation bath. Three batches of samples were prepared and analysed.
2.6.2. Atomic force microscopy (AFM) analysis
The size and morphology of particles were characterised using
Atomic Force Microscopy (AFM, Dimension Icon with ScanAsyst,
Bruker Corporation, U.S.A.). Particle suspensions were dropped on mica
substrates and air dried before placing on the sample stage. AFM
measurements were conducted using SCANASYST-AIR tips and
ScanAsyst mode. The data was analysed with NanoScope Analysis 1.5
software.
2.6.3. Transmission electron microscopy (TEM) analysis
SPPs or MSPPs were dispersed in DI water at the concentration of
0.1 mg/ml. The dispersions were then dropped onto TEM copper grids
and incubated at room temperature for 30 s. Excess solution on grids
was then removed with ﬁlter paper, by gently dapping the edge and
allowing excess liquid to be absorbed prior to TEM imaging (Tecnai G2
Spirit, FEI, USA). An acceleration voltage of 80 kV was used and images
were recorded using a Gatan Orius SC1000B bottom mounted digital
camera and analysed in Gatan Digital Micrograph software (version
3.9.1).
2.7. Cytotoxicity and cell growth inhibition
MDA-MB-231 or HDF cells were seeded into 96-well plates with
200 µl of complete RPMI medium (supplemented with 10% foetal bo-
vine serum (FBS) and 1% L-glutamine) at a density of 5×103 cells per
well and incubated overnight at 37 °C under 5% CO2 atmosphere. The
medium was then removed, and the cells were washed twice with PBS
buﬀer before being replaced with 180 µl serum-free medium. 20 µl of
SPP-ODN or MSPP-ODN complex dispersions with diﬀerent particle/
ODN mass ratios were added into each well. SPP or MSPP solutions
(20 µl) with equivalent amount of particles used for complexation with
ODNs were added into wells. ODN solutions were also used as negative
controls with dosages equivalent to the amount of ODNs used in com-
plexes. Cells were incubated for 4 h initially being exposed to a mag-
netic ﬁeld for 20min. The serum-free medium was then removed and
replaced with 200 µl complete medium and cells were cultured to a
ﬁnal duration of 3 days. Then 50 µl of MTT reagent (3 mg/ml) was
added into each well and cells were cultured for another 3 h until the
purple precipitate was visible. The medium was then removed and
200 µl of DMSO was added into each well before placing plates on a
shaker until purple precipitates in wells were fully dissolved. The ab-
sorbance of each well was measured at 570 nm with a plate reader
(FLUOstar galaxy, BMG LABTECH, Germany).
2.8. Cell transfection and uptake
MDA-MB-231 and HDF cells were seeded in 6-well plates at a
density of 5×105 cells per well with complete medium and incubated
overnight at 37 °C and 5% CO2. The cell culture mediums were re-
moved, and cells were washed twice with PBS before incubation with
serum-free medium. SPP-ODN or MSPP-ODN complexes were added
into diﬀerent wells and incubated for 5, 20min or 1, 4, 24 h with and
without initial exposure to a magnetic ﬁeld for 5 or 20min (the max-
imum exposure time is 20min). ODNs were added as a negative control.
Oligofectamine-ODN was used as a positive control with a standard
incubation time for 4 h in serum-free medium. After incubation, cells
were washed twice with PBS buﬀer before further incubation in the
complete medium to a ﬁnal duration of 24 h. The resulting cells were
harvested with trypsin and analysed with The BD™ LSR II ﬂow cyt-
ometer (BD Biosciences, USA) to investigate the ODN uptake. The data
were analysed by the FlowJo v10 software.
2.9. Magnetically targeted delivery assay
MDA-MB-231 cells were seeded into 6-well plates (with 2 coverslips
in each well) at a density of 3×105 cells per well with complete
medium. After 24 h, cells were washed twice with PBS buﬀer before
incubation in serum-free medium. Cells were incubated with naked
ODNs, Oligofectamine-ODN, SPP-ODN and MSPP-ODN complexes for
4 h. The magnetically targeted delivery was conducted by placing a
circular neodymium magnet under one of the coverslips in each well for
20min at the start of incubation. After initial incubation, cells were
washed twice with PBS buﬀer to remove free ODNs and transfection
complexes followed by a further incubation in complete medium to a
total incubation time of 24 h. The cells were then washed twice with
PBS and ﬁxed with 4% paraformaldehyde. The ﬁxed cells were stained
with Alexa Fluor 568 Phalloidin and DAPI for 1 h. The confocal ﬂuor-
escence images of cellular uptake of ODNs were observed with an
Inverted Zeiss LSM 510 NLO microscope (Zeiss, Germany) and analysed
with LSM Image Browser software (version 4.2.0.121).
2.10. Statistical analysis
The statistical analysis of the data was carried out by using
GraphPad Prism 7.02 (t-test).
3. Results and discussion
3.1. Characterization of SPPs and MSPPs
3.1.1. Size, zeta potential and morphology of SPPs
SF forms aggregates in high concentration salt solutions such as
sodium phosphate. The salting-out of SF is resulted from the competi-
tion of free water molecules between the protein molecules and salt
ions (Scopes, 2013). At low salt concentrations the hydrophobic amino
acids in SF are protected by hydrophilic amino acids which interact
with the surrounding water molecules (Scopes, 2013). With increasing
salt concentration more water molecules are attracted by salt ions
leading to a decrease in the number of water molecules interacting with
SF proteins, therefore resulting in increased hydrophobic interactions
between SF chains, inducing the formation of SF aggregates (Scopes,
2013). During salting-out, micellar-like structures are ﬁrst formed due
to the enhancement of hydrophobic interactions between SF protein
chains, followed by further aggregation and ﬁnally particulate SF
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globules (Lammel et al., 2010).
The addition of salt can also be used to induce the aggregation of
PEI (Curtis et al., 2016). PEI is a cationic polymer with hydrophobic
backbones and closely-spaced amines making PEI a highly positive
charged polymer (Curtis et al., 2016). The intra-chain repulsion caused
by the amine groups on the same chain keeps the polymer from ag-
gregating (Curtis et al., 2016). If the charges on the hydrophobic chains
are insuﬃcient e.g. by increasing salt concentration (Curtis et al.,
2016), the hydrophobic backbones will collapse and form aggregates
(Dobrynin and Rubinstein, 1999; Chandler, 2005). Adding a small
amount of salt into PEI solution increases the PEI solubility and pre-
vents its aggregations due to the fact that the attractive interactions
between hydrophobic chains are counterbalanced by the electrostatic
repulsion at low ionic strength (Curtis et al., 2016). The solubility of PEI
reached a maximum at 150mM NaCl concentration. Further increasing
the salt concentration resulted in the salt screening of the electrostatic
repulsion therefore decreasing intra-chain repulsion resulting in PEI
aggregations via hydrophobic interactions (Curtis et al., 2016).
PEI particles were prepared by adding PEI solution (5mg/ml) into
sodium phosphate solution (pH 8) at an ionic strength of 1.25M. After
an incubation time of 6 h at room temperature aggregations were ob-
served. The particle size was then analysed using DLS as shown in
Fig. 1a, which indicated that the mean diameter of PEI particles was
85 nm. The addition of diﬀerent ratios of SF into the PEI solution re-
sulted in the increasing of particle size (Fig. 1a). Increasing the SF ratio
lead to accelerated aggregation of SPPs as well as increased particle
yield. When using a mixture containing 90% SF (5mg/ml) and 10% PEI
(5mg/ml), the SPP aggregation was almost immediate upon added into
salt solution. As shown in Fig. 1a, the size of SPPs increased from 107 to
436 nm when increasing SF content from 10% to 90%.
This phenomenon is most likely due to the inter-chain attractions
between positively charged PEI chains and negatively charged SF
chains. When a small amount of SF was added to PEI solutions, negative
SF chains were attracted and electrostatically bound to positive PEI
chains, weakening the charge density of PEI chains. With increasing
amount of SF, PEI chains are neutralized and the backbone charge
becomes insuﬃcient to keep the molecules extended after the mixtures
being added into salt solutions (Curtis et al., 2016). This is supported by
the SPPs zeta potential measurements (shown in Fig. 1a), where the
zeta potential decreases with increasing SF content. A zeta potential of
+50mV was observed for PEI particles. The strong electrostatic re-
pulsions among PEI particles resulted in small particles (85 nm). An
addition of 10% SF in PEI solution reduced the zeta potential of SPPs to
+45mV, increasing the mean particle diameter to 107 nm (Fig. 1a).
Further increasing the SF content lead to lower zeta potentials and
larger SPP particle sizes, where 90% SF resulted in a zeta potential of
+32mV. At 95% SF content the SPPs were almost electroneutral (zeta
potential: +7.3mV) and large amount of precipitate was observed. The
changes of particle size and zeta potential dependant on the SF/PEI
ratio give strong indication of hybrid particle formation.
In addition to DLS analysis the size and morphology of SPPs were
also determined using AFM. As shown in Fig. 2af, spherical particles
with smooth surfaces were observed. PEI-only particles (Fig. 2a)
showed diameters ∼80 nm, in contrast to SPPs, where particles with
diameters of over 400 nm were observed for the highest SF content
(90%, Fig. 2f), which is consistent with the particle sizes given by DLS.
In order to reveal the structures of the SPPs, TEM analysis was under-
taken. Fig. 2g shows small PEI particles with diameters of ∼30 nm
aggregated to form larger particles (∼100 nm). The structures of SPPs
with 50%, 75% and 90% of SF are shown in Fig. 2h, i&j, respectively.
Increasing diameters of ∼200 nm, ∼260 nm and ∼400 nm were ob-
served from these particles respectively, which was consistent with the
results given by DLS and AFM. SPPs with 90% of SF (SPP90) shown in
Fig. 2j clearly show that the particle formed by the aggregation of many
smaller particles with diameters ranging from 30 to 100 nm, conﬁrming
that increasing SF content resulted in lower surface charge and lead to
particle aggregation.
3.1.2. Size, zeta potential and morphology of MPPs and MSPPs
MPPs were fabricated by adding PEI (5 mg/ml) to MNPs suspended
in sodium phosphate solution. Zeta potential measurements revealed
negative charges of −12.6 mV for MNPs and high positive charges of
+48.5mV for MPPs (see Fig. 1b), which are in agreement with pre-
vious reports by Wang et al. (2009) and Zhao et al. (2014). These
measurements strongly suggest that negatively charged MNPs have
been coated with positive PEI molecules which adsorb onto the surface
of MNPs through electrostatic attractions and Van der Waals forces
(McBain et al., 2007) before aggregating and entirely covering the MNP
in the ﬁnal salt solutions (Curtis et al., 2016). DLS measurements of
MNPs revealed average particle diameters of 109 nm and increased to
131 nm after PEI coating (see Fig. 1b), similar to the results reported by
Ota et al. (2013) previously.
The particles were further characterised by AFM to investigate the
morphologies of MNPs, MPPs and MSPPs. AFM revealed that the MNPs
exhibited rough surfaces with particle sizes ranging between 10 and
30 nm (Fig. 3a), while MPPs were ∼110 nm in diameter (Fig. 3b)
supporting the conclusion that the MNP surfaces were coated with PEI
polymers. It should be noted that MNPs size measurements with AFM
show a signiﬁcantly smaller particle size than DLS measurements,
which is most likely due to MNP particle aggregation occurring in the
suspensions during the DLS measurement. Further to this, TEM analysis
of MPPs reveals a core-shell type structure as shown in Fig. 3g. The core
phase consisted of Fe3O4 nanoparticles, represented by the dark regions
of the image compared to the shell structure of the PEI polymer in grey.
Fig. 1. Eﬀect of SF (5mg/ml)/PEI (5 mg/ml) ratio on the size and zeta potential of SPPs (a), and MSPPs (b). The increase of SF ratio resulted in the increase of the size
of SPPs and MSPPs, and also resulted in the decrease of the zeta potential of SPPs and MSPPs. SPP (or MSPP) 10, 25, 50, 75, 90 & 95 represent SPPs (or MSPPs) with
10%, 25%, 50%, 75%, 90% & 95% of SF. The results are shown in mean ± SD, n≥ 3.
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Fig. 2. AFM and TEM images of the PEI particles (a&g) and SPPs (bj) with diﬀerent amount of SF: 10% (b), 25% (c), 50% (d&h), 75% (e&i) and 90% (f&j). The
increase of SF amount resulted in the increase of particle sizes.
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Fig. 3. AFM and TEM images of the MNPs (a), MPPs (b&g), and MSPPs with 10% (c), 50% (d&h), 75% (e&i), and 90% (f&j) of SF.
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TEM images clearly revealed (Fig. 3g) that smaller MPPs of the order of
∼20 nm aggregated and formed larger aggregated particles of
∼100 nm in diameter, consistent with the AFM data. Steitz et al. (2007)
previously reported that coating with PEI polymers can bridge two or
more particles together and form larger aggregations through Van der
Waals forces. On the other hand, MPPs are strongly positively charged
due to a large amount of amine groups in PEI, resulting in strong
electrostatic repulsions among MPPs and thus enabling better disper-
sion of these particles. The balance between Van der Waals forces and
electrostatic repulsions resulted in such aggregate size of MPPs.
Changes of the electrostatic charges on the surface of the particles will
however lead to diﬀerent aggregate sizes.
Further to the synthesis of MPPs above, the PEI (5 mg/ml) was
mixed with diﬀerent ratios of SF (5mg/ml) before they were coated
onto MNPs. The resulting particle sizes and zeta potentials measured
(by DLS) were also shown in Fig. 1b. The mixed polymer shell of SF and
PEI resulted in diﬀerent surface charges and aggregation sizes of
MSPPs. The addition of SF reduced the zeta potential of MSPPs com-
pared with MPPs indicating negatively charged SF and positively
charged PEI had co-aggregated on the surface of MNPs. By altering the
SF/PEI ratio both particle size and zeta potential are controllable as
shown in Fig. 1b. For example, 10% of SF in PEI resulted in a decreased
zeta potential of +42mV and an increased average diameter of 167 nm
for MSPPs. Increasing the SF to 90% resulted in even lower zeta po-
tential (+29mV) and larger particle diameter (319 nm). The increased
aggregate size can be explained by reduced electrostatic repulsions
between particles, causing MSPPs to form aggregates through Van der
Waals forces more readily. At a SF content of 95% a near neutral sample
was produced having a zeta potential of +5.7mV with almost all the
particles precipitated out, suggesting there was insuﬃcient electrostatic
repulsion between particles to keep them from aggregating.
Morphologies of MSPPs were analyzed by AFM and TEM. As shown
in Fig. 3cf, the size of MSPPs increased with increasing SF content,
which is consistent with measurements by DLS. Spherical and smooth
particles were observed, suggesting the surfaces of MNPs were coated
by SF-PEI polymer mixture. Similar to SPPs, AFM images for MSPPs
revealed smaller particles around larger ones (Fig. 3cf), suggesting the
large particles were aggregations of small MSPPs. TEM images of MSPPs
(at 50%, 75% and 90%) shown in Fig. 3hj reveal that MSPPs were
formed by multiple Fe3O4 cores covered by SF-PEI shells. The inset in
Fig. 3j is an enlarged section of the image (red boxed area). Altering the
SF content did not show any eﬀect on the size of the smaller core-shell
magnetic nanoparticles which were consistently around 20 nm in dia-
meter. However, the increased SF percentage resulted in larger ag-
gregates supporting the previous AFM and DLS data.
Finally, it is worth to note that positive zeta potential in excess of
+28mV were observed even at low PEI contents (10%) in SF-PEI
mixtures. This is due to the high charge density of PEI (Smits et al.,
1993). This phenomenon is favorable for the fabrication of low toxic
cationic carriers for DNA transfection. DNA is able to adsorb onto the
carrier surface via electrostatic attractions, demonstrating the im-
portance of positive charges for DNA adsorption (Zhang et al., 2016;
Steitz et al., 2007).
3.2. Interaction of MSPPs with c-myc antisense ODNs
For successful gene transfection, vectors are normally required to
condense the DNAs (Ono and Spain, 1999; Arscott et al., 1990;
Andrushchenko et al., 2002). The mechanisms by which DNAs form
complexes with transfection vectors has been reported and morpholo-
gies of the complexes have been previously characterized by AFM (Zhao
et al., 2014; Andrushchenko et al., 2002; Danielsen et al., 2004; Volcke
et al., 2006). Single stranded ODNs are diﬀerent to plasmids and long
linear DNAs in both molecular weight and topography which may result
in diﬀerent pathways in condensation and forming complexes (Chen
et al., 2006). It is therefore important to investigate the formation of
MSPP-ODN complexes and their assembly mechanism. The morpholo-
gies of naked ODNs and the resulting complexes were characterized by
AFM. For the naked ODN, spherical structures with diameters ranging
from 30 to 40 nm and heights of 2 to 3 nm were observed (see Fig. 4a),
similar to the ODN self-assembled structures previously reported by
Costa et al. (2004). Nanowires were also observed, similar to the ones
reported by Chiorcea-Paquim et al. (2013), having lengths of over
500 nm and heights ranging from 2.5 to 3.5 nm (Fig. 4a). As the ODNs
used in this research are only 15 nucleotides, the large scaled nanos-
tructure is most likely to be a higher order structure of self-assembled
ODNs (Chen et al., 2006; Costa et al., 2004; Chiorcea-Paquim et al.,
2013; Chiorcea-Paquim et al., 2013). The self-assembly of guanine (G)
rich ODNs into higher order nanostructures such as networks and long
nanowires (Chiorcea-Paquim et al., 2013) has been previously reported
(Chen et al., 2006; Costa et al., 2004; Chiorcea-Paquim et al., 2013;
Chiorcea-Paquim et al., 2013).
Fig. 4b&c are representative AFM images of ODNs that were mixed
under gentle shaking with MSPPs with 90% SF (MSPP90) at a mass
ratio of 12:1 after 30 s (b) and 30min (c) condensation time. After 30 s,
condensed nanoﬁber-like structures and aggregations of nanowires
were observed (Fig. 4b), similar to the nanostructures reported by Chen
et al. (2006) who mixed a 21-nt ODN with polypropyleneimine (PPI)
followed by a 10min condensation time. The height of the condensed
nanoﬁbers ranged from 2 to 15 nm and diameters of aggregated
structures from 80 to 300 nm, suggesting that the free ODNs were
condensed by MSPP90. After 30min condensation time well-condensed
MSPP-ODN complexes were formed as shown in Fig. 4c, consisting of
spheroidal particles with diameters of 100 nm350 nm and heights
ranging from 10 to 20 nm. Rough surfaces morphologies were observed
as a result of ODN complexation on particle surfaces. Comparable
spheroidal condensates have also been reported in previous studies
(Andrushchenko et al., 2002; Danielsen et al., 2004; Volcke et al., 2006;
Chen et al., 2006; Costa et al., 2004). ODNs were most likely interacted
with MSPPs through electrostatic attractions and produce nanoﬁbers
during the initial condensation process (Fig. 4d). At longer condensa-
tion times (30min), ODN chains tightly wrapped around the MSPPs and
spheroidal MSPP-ODN complexes were formed.
3.3. In vitro cytotoxicity assay
3.3.1. Inhibition eﬀect of MSPPs and MSPP-ODN on MDA-MB-231 cells
C-myc oncogene is an evolutionarily conserved gene expressed in
many cell types including MDA-MB-231 breast cancer cells (Junghans
et al., 2000). It is often associated with many essential biological pro-
cesses including cell growth, proliferation, transformation and apop-
tosis (Junghans et al., 2000; Gu et al., 2017). Disordered expression of
the c-myc gene will lead to malignant transformation of cells (Junghans
et al., 2000). Down regulation of the expression of c-myc by exposing
the cancer cells to c-myc antisense ODN has been reported to be able to
inhibit cancer cell growth (Junghans et al., 2000; Leonetti et al., 1996;
Watson et al., 1991). c-myc antisense ODN is a single-stranded nucleic
acid designed to speciﬁcally bind to the target mRNA through the
Watson-Crick base pair complementarity to form duplexes
(Santhakumaran et al., 2004). This therefore blocks the translation of
the target gene or alternatively, the RNase H can be activated to digest
the speciﬁc mRNA (Zhao et al., 2007; Santhakumaran et al., 2004).
High eﬃcacy was expected for antisense ODNs due to its speciﬁcity to
target mRNAs (Santhakumaran et al., 2004). However, the application
of c-myc antisense ODNs is limited by major hurdles such as poor de-
livery and cellular uptake of naked ODNs into the target tissue along
with their poor in vivo stability (Zhao et al., 2007; Santhakumaran et al.,
2004; Mumcuoglu et al., 2016; Petrilli et al., 2014). The inherent hy-
drophilicity and negative charges of ODNs make it very diﬃcult for
them to approach and cross the hydrophobic cell membranes into the
cytoplasm or nucleus (Gangar et al., 2013). Therefore, large amount of
ODNs and long incubation times are needed for the observation of any
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cell growth inhibition eﬀect when the cells are treated with naked ODN
(Balaji et al., 1997; Leonetti et al., 1996; Watson et al., 1991). For ex-
ample, in the study by Watson et al. (1991) 4 days were required for the
observation of initial inhibition for MDA-MB-231 cells exposed to 5 μM
c-myc antisense ODN. In another study, Leonetti et al. (1996) added
100 μg/ml c-myc antisense ODN to M14 cells and only after 4 days
growth inhibition could be observed. These illustrate the need for ef-
ﬁcient transfection systems for antisense gene delivery to solve the
above problems (Pan et al., 2007). Various vectors have previously
been developed and have shown improved inhibition eﬃciency at
lower ODN dosages (Zhao et al., 2007; Pan et al., 2007; Sarkar et al.,
2005; Pan et al., 2009). However it is clear that vast improvement is
still needed for eﬃcient systems.
MTT assay in Fig. 5 shows that negligible growth inhibition was
observed for MDA-MB-231 cells treated with naked ODNs (red col-
umns), indicating that eﬃcient transfection was diﬃcult for naked
ODNs due to its poor cellular uptake. The increased dosage of MPPs and
MSPPs resulted in decreased viability of MDA-MB-231 cells treated with
those particles, indicating that MPPs and MSPPs possessed dose-de-
pendent cytotoxicity to MDA-MB-231 cells. The introduction of SF into
the MPPs system reduced the cytotoxicity of MPPs. Cells treated with
MSPPs (at 5090% SF) showed a higher viability than those treated
with MPPs (blue columns). At the same MSPP dose, cell viability in-
creased with the increase of SF content in MSPPs. For example, at the
concentration of 50 μg/ml (associated with the MSPP/ODN ratio of
50:1) MDA-MB-231 cells showed the viabilities of 58%, 73%, 77% and
85% after treated with MPPs, and MSPPs with 50%, 75% and 90% of SF
respectively, giving strong evidence that the addition of SF resulted in
reduced cytotoxicity of MSPPs.
By increasing mass ratios of MPPs/ODN from 1:1 to 100:1 a clear
decrease in cell viability can be seen (Fig. 5a), where at lower mass
ratios from 1:1 to 25:1 cells treated with MPP-ODN exhibited a sig-
niﬁcantly lower viability to those treated with MPPs. All these lowered
cell viabilities indicate that c-myc antisense ODN induced cell growth
inhibition occurred. However, at higher ratios (50:1100:1) no sig-
niﬁcant diﬀerence on viabilities were observed between cells treated
with MPPs and MPP-ODN, suggests the inhibited cell growth mainly
have been a result from the cytotoxicity of MPPs and shield the eﬀect of
ODNs. On the other hand, as shown in Fig. 5bd, on average a ∼20%
lower viability for MDA-MB-231 cells treated with MSPPs (5090% SF)-
ODN to those treated with MSPPs (5090% SF) was observed at the
whole ratio range investigated, indicating that MSPPs with SF are
capable of transfecting the ODN for the inhibition of cell growth. It is
important to note that even at higher particle/ODN ratios (50:1100:1)
cells showed signiﬁcantly lower viabilities after treated with MSPP-
ODN to those treated with MSPPs (5090% SF), suggesting the reduced
viabilities were mainly attributed to the function of ODN instead of
toxicity of MSPPs. These results indicated that with reduced cytotoxi-
city compared to MPPs, MSPPs (5090% SF) allow the eﬃcient growth
inhibition performance of ODN without bringing signiﬁcant cytotoxi-
city of carriers to cells, which is desired in gene transfection.
Since MSPP90 showed the lowest toxicity among these particles
(MSPPs 5090% SF) and is still capable of transfecting the c-myc an-
tisense ODN to cause the growth inhibition of MDA-MB-231 cells, it is
of interest to investigate its optimum mass ratio with ODN to achieve
high inhibition eﬀect from ODN while avoid additional cytotoxicity
from MSPP90. As shown in Fig. 5d, when the MSPP/ODN mass ratio
was 1:1, MSPP90-ODN exhibited the lower inhibition eﬀect than other
MSPP-ODN complexes, which was most likely because insuﬃcient
MSPP90 were provided at such mass ratio. Increased mass ratio from
1:1 to 12:1 resulted in decreased viabilities for cells treated with
MSPP90-ODN, suggesting the growth inhibition eﬀect was enhanced
Fig. 4. AFM images of ODNs (a) and MSPP90-ODN complexes (b&c). The AFM images were taken after 30 s (b) and 30min (c) condensation respectively. MSPP90/
ODN mass ratio was ﬁxed at 12:1. (d) Schematic representation of the possible mechanism for the condensation of ODNs by MSPPs. ODN chains wrapped around the
MSPPs to form spheroidal MSPP-ODN complexes.
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with increased amount of MSPPs in MSPP90-ODN, which is most likely
because the increased surface charge of complexes making them easier
to interact with cell membrane and to be internalized. With further
increase of the MSPP90/ODN ratio from 12:1 to 25:1 the viability of
MSPP90 treated cells decreased from 96% to 90% without observation
of signiﬁcant viability decrease for cells treated with MSPP90-ODN
complexes (only from 72% to 70%), indicated that the optimum
MSPP90-ODN mass ratio for MDA-MB-231 cell growth inhibition at the
ODN concentration of 1 μg/ml was 12:1. MDA-MB-231 cells treated
with SPP90 and SPP90-ODN showed a similar growth inhibition pattern
to those treated with MSPP90 and MSPP90-ODN, suggesting both
particles possess similar cytotoxicity towards MDA-MB-231 cells.
It has been previously reported that the signiﬁcant cytotoxicity of
PEI is thought to be mainly due to its high amine content that resulted
in high cationic charge density (Seow et al., 2013; Xue et al., 2014;
Bansal et al., 2016; Ghiamkazemi et al., 2010). Free PEI molecules can
interact with negatively charged substances such as serum proteins or
even red blood cells to form aggregates which can adhere to tissue
surfaces to cause signiﬁcant cell damage (Xue et al., 2014). PEI is also
able to interact with proteins inside the cell and therefore interfere with
critical intracellular processes (Forrest et al., 2003). Many studies have
been conducted to reduce the surface charge of PEI based transfection
systems in order to minimum their cytotoxicity. For example, Xue et al.
(2013) encapsulated hexadecylated-PEI polymers/siRNA complexes in
negative charged lipids, the resulting surface charge of encapsulated
complexes were decreased as well as the cytotoxicity compared with
un-encapsulated PEI complexes. In another example, Liu et al. (2014)
designed ASF/PEI/DNA ternary complexes by coating negatively
charged Antheraea pernyi silk ﬁbroin (ASF) onto the surface of PEI/DNA
complexes. The coating of ASF resulted in fewer surface charges and
therefore a higher viability of cells transfected with ASF/PEI/DNA
ternary complexes was observed compared to those transfected by PEI/
DNA complexes. Therefore, it is believed that the reduced cytotoxicity
of MSPPs is resulted from the reduced surface charge on these particles.
3.3.2. Concentration eﬀect of particles/complexes on MDA-MB-231 and
HDF cells
To investigate the inhibition eﬀect of MSPP-ODN and SPP-ODN at
diﬀerent concentrations on cancer and normal cells, MDA-MB-231
breast cancer cells and human dermal ﬁbroblast (HDF) were selected
and treated with SPP90-ODN, MSPP90-ODN, SPP90 and MSPP90.
MSPP90 was chosen because it exhibited the lowest cytotoxicity among
MSPPs with diﬀerent SF percentages and SPP90 was chosen as a com-
parison with MSPP90. MSPP90 and SPP90 were mixed with ODN at a
mass ratio of 12:1 before incubating with MDA-MB-231 or HDF cells in
serum-free medium for 4 h. The ﬁnal concentrations of ODN in medium
were 1, 5 and 10 μg/ml. A magnet plate was placed below the cells for
the ﬁrst 20min of the initial incubation. After initial incubation, the
cells were washed twice with PBS to remove any un-internalized par-
ticles and complexes before incubation in complete medium for a ﬁnal
duration of 3 days.
As shown in Fig. 6, naked ODN showed negligible growth inhibition
eﬀect on both MDA-MB-231 cells and HDF cells at the concentrations
studied, suggesting that the growth inhibition eﬀect of naked ODN was
poor to both cells due to its poor internalization properties (Zhao et al.,
2007; Santhakumaran et al., 2004; Mumcuoglu et al., 2016; Petrilli
Fig. 5. MTT assay of MDA-MB-231 cells after 72 h incubation with diﬀerent complexes: MPP-ODN (a), MSPP50-ODN (b), MSPP75-ODN (c), SPP90 and MSPP90-ODN
(d) at diﬀerent particle/ODN mass ratios (1:1100:1). Complexes were added into serum-free MDA-MB-231 cell cultures for a 4 h transfection time, after which cells
were washed with PBS and further incubated in complete mediums to a ﬁnal duration of 3 days. At the beginning of transfection, the cells were exposed to a magnetic
ﬁeld for 20min. Corresponding carriers and ODN-only with the amounts equivalent to the dosages in complexes were also used as controls to investigate their
toxicity to MDA-MD-231 cells. The dosages of ODN were ﬁxed at 1 μg/ml. The results are shown in mean ± SD, n=4. The statistical signiﬁcance is expressed as
***p < 0.001, **p < 0.01, *p < 0.05.
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et al., 2014). Increasing the concentration of MSPP90 in medium re-
sulted in decreased viability of MDA-MB-231 cells, which is consistent
with the previous results obtained (see Fig. 5). This result strongly
suggests that MSPP90 possess dose-dependent cytotoxicity to MDA-MB-
231 cancer cells. After treatment with MSPP90-ODN, MDA-MB-231
cells showed signiﬁcantly lower viability than cells treated with naked
ODN and MSPP90, suggesting the complexation with MSPP90 have
improved the eﬀect of ODN. With the increased concentration from 1
[C] to 5 [C] and 10 [C], the viability of MDA-MB-231 cells treated with
MSPP90-ODN decreased from 72% to 57% and 41%. While cells treated
with MSPP90 showed the decreased viability of 96%, 82% and 75%.
This result suggested that enhanced growth inhibition eﬀect of
MSPP90-ODN can be achieved without brought massive cytotoxicity
from MSPP90.
Fig. 6b presents the viability of HDF cells after being treated with
naked ODNs, MSPP90, SPP90 and their ODN complexes. It was ob-
served that HDF cells were less aﬀected by the particles and complexes.
For example, after both cell lines being treated with MSPP90-ODN at
the same concentration (1[C]), HDF cells exhibited a higher viability
(92%) compared to that of MDA-MB-231 cells (72%). This is because
cancer cells tend to exhibit a higher uptake eﬃciency on particles than
normal cells due to the higher metabolic activity of cancer cells (Chaves
et al., 2017) which leads to the overexpression of receptors on their
surface and increases the available binding sites (Chaves et al., 2017;
Kettler et al., 2014; Kohler et al., 2005). Furthermore, it has been re-
ported that diﬀerences in cell-cell interactions between normal cells
and cancer cells can also lead to faster particle uptake for cancer cells
than normal cells (Gal et al., 2015). Gal et al. (2015) compared the
internalization of polystyrene particle by MDA-MB-231 breast cancer
cells and MCF-10A benign cells. The result indicates that cancer cells
uniformly internalize particles in larger amounts and higher rate.
However, only cells at the edge of a growing colony of benign cells are
able to internalize particles (Gal et al., 2015). This is due to the fact that
normal, adherent cells maintain tight cell-cell connections (Hazan et al.,
2000). In contrast, cell-cell and cell-matrix interactions are less im-
portant for cancer cells, and particles can thus be internalized into any
cell on the plate at high rates (Gal et al., 2015; Hazan et al., 2000).
Therefore, it can be assumed that MDA-MB-231 cancer cells have taken
up more MSPP90-ODN compared to HDF cells, which in turn resulted in
the lower viability of MDA-MB-231 cells.
3.4. Cellular uptake assays
3.4.1. Uptake eﬃciency of MSPP-ODN and SPP90-ODN on MDA-MB-231
cells
Slow vector accumulation and the consequently low vector con-
centration at target tissues is reported as a strong obstacle for eﬃcient
gene transfection (Luo and Saltzman, 2000). By applying a magnetic
ﬁeld, magnetic vectors combining DNAs can be rapidly concentrated
onto the surface of target cells which can facilitate complex inter-
nalization and enhanced transfection eﬃciency (Ma et al., 2011). This
is also known as magnetofection. For non-magnetofection vectors,
their improved accumulation property is based on their designed bio-
physical properties or coupling with targeting ligands. However, in
practise, it has been proved insuﬃcient for rapid accumulation on
target sites (Ma et al., 2011). On the other hand, magnetofection has
shown outstanding performance in rapid transfection (Ma et al., 2011;
Mykhaylyk et al., 2007; Krötz et al., 2003). Mykhaylyk et al. (2007)
compared the transfection performance of magnetic and non-magnetic
complexes exposed to a magnetic ﬁeld. Their data showed that the
magnetic complexes concentrated onto the surface of target cells and
consequently transfection eﬃciencies were found 1000-fold higher than
the transfections conducted with non-magnetic vectors (Mykhaylyk
et al., 2007). Krötz et al. (2003) reported that magnetic particle-ODN
complexes can be transfected into 84% of human umbilical vein en-
dothelial cells within 15min followed by nuclear accumulation within
2 h when exposed to a magnetic ﬁeld, this is substantially faster than
non-magnetofection methods which generally require 24 h incubation
times.
To investigate the uptake kinetics of MPPs, MSPPs and SPPs, par-
ticles were complexed with ﬂuorescence labelled ODNs at the mass
ratio of 12:1. The ﬁnal concentration of ODN was ﬁxed at 1 μg/ml. The
transfection experiment was conducted as described in Section 2.8. As
shown in Fig. 7a, with magnetofection, 81% of MDA-MB-231 cells in-
cubated with MPP-ODN took up the complexes with 5min of incuba-
tion which was followed by washing the cells in PBS buﬀer twice and
24 h of further cultivation in complete medium. This resulted in a 3.1
fold increase of transfected cells compared with cells treated with MPP-
ODN without a magnetic ﬁeld (26%). This result supports previous
studies which claimed that magnetofection can provide outstanding
performance in rapid transfection compared to non-magnetofection
(Ma et al., 2011; Mykhaylyk et al., 2007; Krötz et al., 2003). Increasing
magnetofection time to 20min only resulted in an increased uptake
eﬃciency of 1% (from 81% to 82%). A further increase to the magne-
tofection to 24 h ﬁnally resulted in the highest uptake eﬃciency of
88%. This indicated that most MPP-ODN complexes were concentrated
Fig. 6. Concentration eﬀect of particles and complexes on breast cancer cells (a) and HDF cells (b). MDA-MB-231 cells and HDF cells were incubated with ODNs,
MSPP90, SPP90, MSPP90-ODN, SPP90-ODN complexes for 4 h in serum-free medium. At the beginning, the cells were treated with an external magnetic ﬁeld for
20min. After the initial transfection, cells were washed twice with PBS buﬀer and incubated in complete medium for a ﬁnal duration of 3 days. [C]=12 μg/ml
MSPP90 or SPP90+1 μg/ml ODN. Equivalent amount of ODN, MSPP90 and SPP90 were used as controls. The results are shown in mean ± SD, n= 4. The
statistical signiﬁcance is expressed as ***p < 0.001, **p < 0.01, *p < 0.05.
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on the surface of cells within the ﬁrst 5 min and extending the mag-
netofection time did not signiﬁcantly increase the uptake eﬃciency.
The result is in agreement with Krötz et al. (2003) who found no further
enhancement of uptake eﬃciency was observed when extending the
magnetofection time from 15min to 24 h for human umbilical vein
endothelial cells incubated with p22phox-antisens ODN containing
magnetic vectors. For the MMDA-MB-231 cells treated with MPP-ODN
without the presence of a magnetic ﬁeld, increasing transfection time to
20min increased the uptake eﬃciency by 43% (from 26% to 69%) and
a further increase to a total of 86% was seen for a transection time of
24 h, showing a clear time-dependent uptake of complexes through
non-magnetofection. This is because the association of vectors to cells is
a diﬀusion-limited process (Plank et al., 2003) which means only a
fraction of the vectors interacted with the cells within the initial short
period (e.g. 5 min). Therefore, increasing transfection time resulted in
the signiﬁcantly increase of complex uptake (Plank et al., 2003).
After 4 h transfection with Oligofectamine-ODN, ODNs uptake was
found 58.3% for cells exposed to the magnetic ﬁeld and 57.5% for cells
Fig. 7. Cellular uptake assays of MPP-ODN (a), MSPP50-ODN (b), MSPP75-ODN (c), MSPP90-ODN and SPP90-ODN (d) complexes for MDA-MB-231 cells. The cell
only and ODNs only are used as negative controls with the dosages of ODNs equivalent to the amount of ODNs used for the complexes. Oligofectamine-ODN was used
as a positive control with a standard transfection time of 4 h. The concentration of the complexes was ﬁxed at 12 μg/ml MSPPs+1 μg/ml ODN. Cells were incubated
with ODN or transfection complexes for 5min  24 h with (M+) or without (M−) the presence of an external magnetic ﬁeld for a maximum of 20min. The cells were
then washed twice with PBS buﬀer and cultured with complete medium until to a ﬁnal duration of 24 h before the FACS analysis. The results are shown in
mean ± SD, n≥ 3. The statistical signiﬁcance is expressed as ***p < 0.001, **p < 0.01, *p < 0.05.
Fig. 8. Cellular uptake assays of MDA-MB-231 cells (a) and HDF cells (b) after treated with MSPP90-ODN and SPP90-ODN at diﬀerent concentrations. The cell-only
and ODNs-only are used as negative controls with the ODN dosages equivalent to the amount used for the complexes. Oligofectamine-ODN was used as a positive
control. Cells were incubated with ODN or complexes for 20min with (M+) or without (M−) the presence of an external magnetic ﬁeld. After the initial transfection,
cells were washed twice with PBS and incubated in complete medium to a ﬁnal duration of 24 h before the FACS analysis. The MSPP90/ODN and SPP90/ODN mass
ratio was ﬁxed at 12:1. [C]=12 μg/ml MSPP90 or SPP90+1 μg/ml ODN. The results are shown in mean ± SD, n=3. The statistical signiﬁcance is expressed as
***p < 0.001, **p < 0.01, *p < 0.05.
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Fig. 9. Confocal microscopic images of MDA-MB-231 cells incubated with naked ODNs (a&b), Oligofectamine-ODN (c&d), SPP90-ODN (e&f) and MSPP90-ODN (g&
h). ODNs were labelled with 5-FAM (green). Cell nucleus and cytoskeleton were stained with DAPI (blue) and Alexa Fluor 568 Phalloidin (red). M+ indicates the
presence of a magnet during the incubation and M− indicates the absence of the magnet. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
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not exposed to a magnetic ﬁeld. This clearly suggests that
Oligofectamine-ODN transfection is not dependant on the presence of a
magnetic ﬁeld. The uptake eﬃciency of Oligofectamine-ODN transfec-
tion for 4 h is lower than that of MPP-ODN for 4 h without the presence
of magnetic ﬁeld, which is most likely due to the faster sedimentation of
MPP-ODN than Oligofectamine-ODN due to the higher density of MPPs.
No signiﬁcant diﬀerences were observed for cells incubated with naked
ODNs with or without the presence of a magnetic ﬁeld. Only 1.5%
(M−) and 1.6% (M+) of total cells took up ODNs after being incubated
with naked ODNs for 5min. The uptake eﬃciency appeared to be time
dependent. However, only 12.3% (M−) and 11.6% (M+) uptake eﬃ-
ciencies were achieved when cells were incubated with naked ODNs for
24 h, indicating that it is diﬃcult for naked ODNs to be taken up by
MDA-MB-231 cells. This explains the negligible reduction of cell via-
bility by naked ODNs.
The uptake kinetics of MSPP-ODN complexes are represented in
Fig. 7bd. With the short magnetofection time of 5min, 67%, 64% and
59% uptake eﬃciencies were achieved by MDA-MB-231 cells treated
with MSPP50, MSPP75 and MSPP90, respectively. In contrast, only
23%, 18% and 17% of ODN uptake eﬃciencies were achieved for cells
treated with MSPP50, MSPP75 and MSPP90 through non-magnetofec-
tion. This clearly shows that the uptake eﬃciency of ODNs can be
drastically improved by MSPPs trough magnetofection.
On the other hand, Fig. 7bd revealed that the uptake eﬃciencies of
MSPP-ODN were time dependent. With increased magnetofection time
from 5min to 20min, signiﬁcant increased uptake eﬃciencies (over
70%) were observed for MDA-MB-231 cells treated with MSPP-ODN
with magnetic ﬁeld, suggesting longer transfection period helped the
accumulation of MSPP-ODN to the cell surface. The diﬀerence in uptake
over time is presumably due to the diﬀerence in positive surface
charges between MPPs and MSPPs. As mentioned in Section 3.1.2, the
positive charges of MSPPs are lower than those of MPPs due to the
introduction of negatively charged SF and with the increase of SF the
surface charges of MSPPs decrease further. The decreased surface
charges of MSPPs may be the reason why longer magnetofection times
are required for MSPP-ODN to achieve uptake eﬃciencies similar to
MPP-ODN. However, it is worth to note that a considerably high uptake
eﬃciency (over 70% compare to∼80% ﬁnal uptake eﬃciency at 24 h)
was achieved by MSPP-ODN within 20min. Moreover, when the mag-
netofection time was increased from 20min to 1 h, only limited im-
provements on uptake eﬃciency were observed. The uptake eﬃciencies
obtained from MSPP-ODN were about the same level as those obtained
from MPP-ODN, which required 24 h for MSPP-ODN through non-
magnetofection. Extended magnetofection time from 1 h to 24 h did not
lead to a signiﬁcant increase of uptake eﬃciency for MSPP-ODN, sug-
gesting almost all MSPP-ODN had been taken up by cells within 1 h of
magnetofection. This result demonstrated that MSPPs were capable of
rapidly delivering ODNs into cells through magnetofection.
The uptake kinetics of MDA-MB-231 cells treated with SPP90-ODN
was also investigated. As shown in Fig. 7d. No signiﬁcant diﬀerences on
uptake eﬃciencies were observed for cells incubated with SPP90-ODN
with or without magnetic ﬁeld, suggesting a magnetic ﬁeld had no ef-
fect to the performance of SPPs. After 5 and 20min of transfection time,
lower uptake eﬃciencies were observed for cells treated with SPP90-
ODN (49%, 20min) compared with MSPP90-ODN (51%, 20min) when
there was no magnetic ﬁeld provided. However, slightly higher uptake
eﬃciencies were obtained by SPP90-ODN (69%, 1 h) than MSPP90-
ODN (65%, 1 h) when the transfection time was extended to 1 h or over.
This can be attributed to more PEI in SPP90 than that in MSPP90 with
the same overall weight, therefore facilitating the internalization over
time.
3.4.2. Concentration eﬀect on the uptake eﬃciency of MSPP90-ODN and
SPP90-ODN on MDA-MB-231 cells and HDF cells
The ODN uptake eﬃciency for MDA-MB-231 is shown in Fig. 8a.
Cells were incubated with naked ODNs and complexes at diﬀerent
concentrations for 20min before washed and further incubated for a
ﬁnal duration of 24 h. Fig. 8a clearly shows that increasing the con-
centration of MSPP90-ODN and SPP90-ODN lead to the improved up-
take eﬃciencies for MDA-MB-231 cells, which explains why increased
concentrations of transfection complexes resulted in decreased viability
of cells as shown previously in Section 3.3.2. The uptake eﬃciencies
obtained by Oligofectamine-ODN were 2.7, 5.7 and 3.7-fold higher than
those obtained by naked ODNs at the concentration [C], 5[C] and 10[C]
respectively, suggesting an enhanced uptake eﬃciency can be achieved
by Oligofectamine within a short transfection time of 20min. However,
higher uptake eﬃciencies were obtained by MSPP90-ODN and SPP90-
ODN with or without the presence of a magnetic ﬁeld. In particular,
with a magnetic ﬁeld the uptake eﬃciency of MSPP90-ODN is much
higher. The uptake eﬃciencies by HDFs, as a control of non-cancer
cells, are displayed in Fig. 8b and are signiﬁcantly lower than that of
MDA-MB-231 breast cancer cells. These results explain why both
MSPP90-ODN and SPP90-ODN exhibited a lower growth inhibition
eﬀect to HDF cells compared with MDA-MB-231 cells (see Section
3.3.2).
3.5. Magnetically targeted delivery assay
To investigate the potential of MSPPs for magnetically targeted
delivery of ODNs, MSPP90-ODN were incubated with MDA-MB-231
cells with or without the presence of a magnet. Naked ODNs,
Oligofectamine-ODN and SPP90-ODN were also incubated with cells as
negative controls. As shown in Fig. 9a&b, ﬂuorescence intensities of
cells treated with naked ODNs were seen to be signiﬁcantly lower than
those cells treated with transfection complexes, suggesting naked ODNs
were not eﬃciently internalized by cells, which is consistent with up-
take eﬃciency shown in Fig. 7. Moreover, for cells treated with naked
ODNs (Fig. 9a&b), Oligofectamine-ODN (Fig. 9c&d) and SPP90-ODN
(Fig. 9e&f), the presence of the magnet did not result in any signiﬁcant
diﬀerence to the ﬂuorescence intensities, suggesting that the magnetic
ﬁeld did not change the cellular uptake of these complexes. Fig. 9g&h
reveals the uptake of MSPP90-ODN without and with a magnet placed
under the cells respectively. With the presence of the magnet the ODN
uptake was signiﬁcantly enhanced. The improved ODN uptake is be-
cause large amounts of MSPP90-ODN were concentrated at the area
with a magnet. On the other hand, the local concentration of MSPP90-
ODN at the areas without magnet was signiﬁcantly reduced, thus re-
sulting in a reduced uptake. This result reveals that MSPPs have great
potential to be used for magnetically targeted delivery of ODNs to de-
sired sites.
4. Conclusions
In summary, magnetic-silk/polyethyleneimine coreshell nano-
particles have been fabricated using SF, PEI and MNPs through a simple
salting-out method. The particle size and zeta potential are controllable
by changing the percentage of SF during fabrication. The coreshell
nanoparticles are capable of delivering ODNs into MDA-MB-231 breast
cancer cells and signiﬁcantly inhibiting cell growth. The addition of SF
material resulted in signiﬁcantly reduced cytotoxicity compared to
MPPs. Both SPPs and MSPPs are less toxic to HDF cells than to MDA-
MB-231 cancer cells. High uptake eﬃciency of ODNs (over 70%) was
achieved by MSPPs within a short time (20min) through magnetofec-
tion. Moreover, with the presence of external magnetic ﬁelds, MSPPs
can target deliver ODNs to the desired areas with reduced ODN con-
centrations at non-targeting areas, thus avoiding undesirable side-ef-
fects to healthy tissue. SPPs and MSPPs therefore are promising can-
didates for targeted gene therapy.
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